[HTML][HTML] Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon …

N Yahi, JM Sabatier, P Nickel, K Mabrouk… - Journal of Biological …, 1994 - Elsevier
The infection of human colonic epithelial cells HT-29 by human immunodeficiency virus type
1 (HIV-1) occurs independently of CD4, the main HIV-1 receptor expressed on lymphocytes …

Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential …

J Fantini, DG Cook, N Nathanson… - Proceedings of the …, 1993 - National Acad Sciences
The gastrointestinal tract plays a major role in the pathogenesis and pathophysiology of
infection by the type 1 human immunodeficiency virus (HIV-1). It is a potential route for viral …

Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop

DG Cook, J Fantini, SL Spitalnik, F Gonzalez-Scarano - Virology, 1994 - Elsevier
The primary receptor for the human immunodeficiency virus (HIV) is the CD4 molecule.
However, a large body of evidence has demonstrated that some cells that do not express the …

Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry

J Fantini, D Hammache, O Delézay, N Yahi… - Journal of Biological …, 1997 - ASBMB
Galactosylceramide (GalCer) is an alternative receptor allowing human immunodeficiency
virus (HIV)-1 entry into CD4-negative cells of neural and colonic origin. Several lines of …

Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide

D Long, JF Berson, DG Cook, RW Doms - Journal of virology, 1994 - Am Soc Microbiol
Human immunodeficiency virus type 1 (HIV-1) infects some cell types which lack CD4,
demonstrating that one or more alternative viral receptors exist. One such receptor is …

Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3'sulfo-galactosyl …

JM Harouse, RG Collman… - Journal of virology, 1995 - Am Soc Microbiol
The primary receptor for human immunodeficiency virus (HIV) is the CD4 molecule;
however, in vitro evidence suggests that a neutral glycolipid, galactosyl ceramide (GalCer) …

Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells

N Yahi, S Baghdiguian, H Moreau, J Fantini - Journal of virology, 1992 - Am Soc Microbiol
The gastrointestinal tract is considered to be a major route of infection for human
immunodeficiency virus (HIV). Infection of human colon epithelial cells by HIV is not blocked …

Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the …

Y Furuta, K Eriksson, B Svennerholm… - Proceedings of the …, 1994 - National Acad Sciences
The rectal and genital tract mucosae are considered to be major sites of entry for the human
immunodeficiency virus (HIV) during sexual contact. We now demonstrate that vaginal …

Interferon-γ decreases cell surface expression of galactosyl ceramide, the receptor for HIV-1 gp120 on human colonic epithelial cells

N Yahi, SL Spitalnik, KA Stefano, P De Micco… - Virology, 1994 - Elsevier
Abstract HT-29-A7, a CD4-negative clonal derivative of the human colonic adenocarcinoma
cell line HT-29, is particularly sensitive to infection by several isolates of HIV-1 and …

Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to …

N Yahi, JM Sabatier, S Baghdiguian… - Journal of …, 1995 - Am Soc Microbiol
The glycosphingolipid galactosylceramide (GalCer), which binds gp120 with high affinity
and specificity, is a potential alternative receptor for human immunodeficiency virus type 1 …